Amo Groningen B.v.

Robin Zonneveld

Carmen Canovas Vidal

Robert Rosen

Aixa Alarcon Heredia

Mihai State

Sieger Meijer

Hendrik Albert Weeber

Theophilus Bogaert

Bram Koopman

Bart Cannegieter

Intraocular lenses for reducing negative dysphotpsia (ND) are described herein. An example ophthalmic lens can include an optic () with a central optical zone () disposed about the optical axis (OA) and an attenuation optical zone () disposed about the central optical zone (), wherein the attenuation optical zone () is contiguous with the central optical zone (), and wherein optical power of the ophthalmic lens is gradually reduced within the attenuation optical zone ().

Intraocular lenses for reducing negative dysphotopsia

Intraocular lenses for reducing the risk of posterior capsule opacification (PCO) are described herein. PCO can be reduced with an IOL design that increases the pressure at the posterior capsular bend, for example, by including a sharper edge design, an enlarged optical zone, and/or an increased vault height. An example ophthalmic lens can include an optic () including an anterior surface () defining an anterior side of the optic, a posterior surface () defining a posterior side of the optic, and an edge () arranged between the anterior and posterior surfaces. The edge and the posterior surface can form an angle, where the angle is less than about 90 degrees. Additionally, the ophthalmic lens can have an increased vault height. At least one of the angle or the increased vault height be configured to increase pressure on a capsular bend in a subject's eye.

Intraocular lenses for reducing the risk of posterior capsule opacification

Growing community of inventors

Groningen, Netherlands

Robin Zonneveld